You might be right
There’s little argument that VATE’s Elev8 CBD Iced Tea line is the sexiest line of mass market CPG CBD Beverages on the OTC, with comparatively minimal competition compared to other types of CBD Beverages
That’s a huge magnet for VATE’s prospective shareholders
Elev8 CBD Coffee is a 2nd huge magnet — and they will be adding Bags of CBD Coffee very soon, in addition to Elev8 CBD Coffee in a Can — so they will be serving both the cold RTD on-the-go and hot drink-at-home markets
CBD Coffee & CBD Tea is a very powerful combination
The Hemp Coffee line is a tremendous business as well, so one can argue there are 3 different huge magnets
VATE’s % gain potential from the .02 level is probably tops in the CBD Beverage subsector
But I think CANB is going to give everybody a run for their money, too, as the price ceiling in the CBD Oil sector has historically been very high
They have a small float with no convertible debt and another $4,000,000 in the bank from the private placement at $.029 in August
They also have excellent annual revenue growth, which is what many CBD Oil investors look for in a CBD Oil stock
And they are now fully seed to sale
With an application already in with the Nasdaq — I don’t think we will see any OTC CBD Oil stocks uplist until Spring/Summer 2020 at the earliest, but it’s still a big feather in CANB’s cap
And we have already seen 3 CBD Oil stocks run from $.01 to $.095, $.12 to $9 and $.03 to $.75, so there’s no doubt that there’s a huge pot of sideline money ready to pour into the CBD Oil subsector and they are looking for the next huge runner
It’s going to be fun to watch CANB & VATE run together when the sector warms up again
They’ve been really tied at the hip for awhile now
I wonder which one will separate first?
Sleek
